MENS
Jyong BiotechยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MENS
Jyong Biotech Ltd.
A biotech company based in Taiwan focused on developing and commercializing innovative and differentiated botanical-derived new drugs for the treatment of urological diseases
Pharmaceutical
01/26/2018
06/17/2025
NASDAQ Stock Exchange
32
12-31
Common stock
23F-3, No. 95, Section 1, Xintai 5th Road, Xizhi District, New Taipei City, Taiwan, 221
--
Jyong Biotech Ltd., a Cayman Islands exempted company incorporated on January 26, 2018, conducts business primarily through a wholly-owned subsidiary in Taiwan, China. Jianyongsheng Technology began commercial operations in July 2002 through Health Ever Bio-Tech Co., Ltd., which has been wholly owned by Jyong Biotech Ltd. since August 2018. Jianyongbiotech is a science-driven biotechnology company headquartered in Taiwan, China, dedicated to the development and commercialization of innovative and differentiated new drugs (plant-derived), mainly focusing on the treatment of urinary system diseases, with an initial focus on the US, EU and Asian markets.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
